Evolving concepts of myocardial phenotypes, myocardial injury, cardiovascular consequences and management in patients with SARS-CoV-2 infection

The COVID-19 pandemic is undoubtedly the greatest public health crisis, the most crucial global health calamity of the century, and the most profound biopsychosocial dilemma for humankind since the Second World War. In December 2019, a novel coronavirus strain causing an interstitial pneumonia and acute respiratory distress syndrome (ARDS) emerged from Wuhan, Hubei Province, China; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for occurrence of this disease. The World Health Organization named the clinical syndrome caused by SARS-CoV-2 the coronavirus disease 2019 (COVID-19).(1)